These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25192046)

  • 21. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
    Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of human hypogonadotropic hypogonadism.
    Layman LC
    Am J Med Genet; 1999 Dec; 89(4):240-8. PubMed ID: 10727999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.
    Cariboni A; André V; Chauvet S; Cassatella D; Davidson K; Caramello A; Fantin A; Bouloux P; Mann F; Ruhrberg C
    J Clin Invest; 2015 Jun; 125(6):2413-28. PubMed ID: 25985275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical manifestations of impaired GnRH neuron development and function.
    Kim HG; Bhagavath B; Layman LC
    Neurosignals; 2008; 16(2-3):165-82. PubMed ID: 18253056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome.
    Karges B; Roux N
    Endocr Dev; 2005; 8():67-80. PubMed ID: 15722618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone neuronal migration.
    Schwarting GA; Wierman ME; Tobet SA
    Semin Reprod Med; 2007 Sep; 25(5):305-12. PubMed ID: 17710726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
    Hanchate NK; Giacobini P; Lhuillier P; Parkash J; Espy C; Fouveaut C; Leroy C; Baron S; Campagne C; Vanacker C; Collier F; Cruaud C; Meyer V; García-Piñero A; Dewailly D; Cortet-Rudelli C; Gersak K; Metz C; Chabrier G; Pugeat M; Young J; Hardelin JP; Prevot V; Dodé C
    PLoS Genet; 2012 Aug; 8(8):e1002896. PubMed ID: 22927827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR1 mutations in Kallmann syndrome.
    Villanueva C; de Roux N
    Front Horm Res; 2010; 39():51-61. PubMed ID: 20389085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism.
    Cariboni A; Davidson K; Rakic S; Maggi R; Parnavelas JG; Ruhrberg C
    Hum Mol Genet; 2011 Jan; 20(2):336-44. PubMed ID: 21059704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hypothalamus-pituitary-gonad axis: Tales of mice and men.
    Kaprara A; Huhtaniemi IT
    Metabolism; 2018 Sep; 86():3-17. PubMed ID: 29223677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons.
    Linscott ML; Chung WCJ
    PLoS One; 2019; 14(7):e0220530. PubMed ID: 31361780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of two novel mutations in three Chinese families with Kallmann syndrome using whole exome sequencing.
    Zhang Q; He HH; Janjua MU; Wang F; Yang YB; Mo ZH; Liu J; Jin P
    Andrologia; 2020 Aug; 52(7):e13594. PubMed ID: 32400067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome.
    Cho HJ; Shan Y; Whittington NC; Wray S
    Front Cell Dev Biol; 2019; 7():121. PubMed ID: 31355196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons.
    Oleari R; Caramello A; Campinoti S; Lettieri A; Ioannou E; Paganoni A; Fantin A; Cariboni A; Ruhrberg C
    Development; 2019 Nov; 146(21):. PubMed ID: 31690636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
    Ribeiro RS; Abucham J
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Illuminating the Terminal Nerve: Uncovering the Link between GnRH-1 and Olfactory Development.
    Amato E; Taroc EZM; Forni PE
    bioRxiv; 2023 Sep; ():. PubMed ID: 37693459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.